Prognostic impact of high-intensity lipid-lowering therapy under-prescription after acute myocardial infarction in women.
Orianne WeizmanMarie Hauguel-MoreauVictoria TeaFranck AlbertPaul BarraganJean-Louis GeorgesNicolas DelarcheMathieu KerneisVincent BatailleElodie DrouetEtienne PuymiratJean FerrièresFrançois SchieleTabassome SimonNicolas Danchinnull nullPublished in: European journal of preventive cardiology (2024)
Women suffer from a bias regarding the prescription of high-intensity LLT after AMI, which did not attenuate between 2005 and 2015, with potential consequences on both survival and risk of cardiovascular events.
Keyphrases
- high intensity
- cardiovascular events
- acute myocardial infarction
- polycystic ovary syndrome
- resistance training
- coronary artery disease
- percutaneous coronary intervention
- cardiovascular disease
- cervical cancer screening
- breast cancer risk
- stem cells
- fatty acid
- risk assessment
- bone marrow
- free survival
- atrial fibrillation